실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

8,428+프로그램
40+FDA 승인
3,743+모집 중
ADC 1032·Antibody 4683·CGT 2713차세대 추천 →·Data Tier →
8428프로그램40FDA 승인
2,820오늘 방문
9,854누적 방문
7303갱신 대기S–CData TierS/A/B차세대→Insight1032HER2 breast4683Antibody2713CGT→Psoriasis→NSCLC40FDA 승인
피드Data Tier차세대Insight

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · EbglyssPCSK9 · LDLRepatha · Praluent · LeqvioGLP-1 · incretinSemaglutide · Tirzepatide혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
다음 갱신 D-5 · 마지막 7월 21일
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

erlotinib with cetuximab (erlotinib with cetuximab)

Lung Adenocarcinoma · Lung Adenocarcinoma

#LungAdenocarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbramson Cancer Center at Penn …Phase 2

Capecitabine, Oxaliplatin and Cetuximab (Capecitabine, Oxaliplatin and Cetuximab)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAmsterdam UMC, location VUmcPhase 2

Standard dose cetuximab (Standard dose cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleBeijing HospitalPhase 2

irinotecan, cetuximab, envafolimab (irinotecan, cetuximab, envafolimab)

RAS Mutation; Metastatic Colorectal Cancer · RAS Mutation

#RASMutation#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleHong Kong Nasopharyngeal Cancer…Phase 2

Docetaxel, Cisplatin, 5-FU and Cetuximab (Docetaxel, Cisplatin, 5-FU and Cetuximab)

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGruppo Italiano per lo studio d…Phase 3

Irinotecan/Cetuximab (Irinotecan/Cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleKing Faisal Specialist Hospital…Preclinical

Capecitabine (Xelodaâ, Capecitabine, Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®))

Colon Rectal Cancer Duke Stage Stageval · Colon Rectal Cancer Duke Stage Stageval

#ColonRectalCancerDukeStageStagev#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystalePresage BiosciencesPhase 1

TAK-981 + Cetuximab (TAK-981 + Cetuximab)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystalePresage BiosciencesPhase 1

TAK-981 + Avelumab (TAK-981 + Avelumab)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib + cetuximab β (Pancreatic cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib +Nimotuzumab (Pancreatic cancer: Tunlametinib +Nimotuzumab)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleUniversity of Medicine and Dent…Phase 2

Capecitabine and Cetuximab (Capecitabine and Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleUniversity of Colorado, DenverPhase 1

IPI-926 and Cetuximab (IPI-926 and Cetuximab)

Recurrent Head and Neck Cancer · Recurrent Head and Neck Cancer

#RecurrentHeadandNeckCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 1

administered with & without Cetuximab (Irinotecan, Irinotecan (administered with & without Cetuximab))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe First Hospital of Jilin Uni…Phase 2

Levofolinic Acid + 5-FU continuous infusion + irinotecan HCl liposome ± cetuximab/bevacizumab (Levofolinic Acid + 5-FU continuous infusion + irinotecan HCl liposome ± cetuximab/bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleDaping Hospital and the Researc…Phase 2

TP + Cetuximab + Tislelizumab (TP + Cetuximab + Tislelizumab)

LA HNSCC · LA HNSCC

#LAHNSCC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleHanmi Pharmaceutical Company Li…Phase 1

HM95573, cetuximab (HM95573, cetuximab)

Locally Advanced Solid Tumor; Metastatic Solid Tumor · Locally Advanced Solid Tumor

#LocallyAdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleGroupe Oncologie Radiotherapie …Phase 2

Carbo, 5FU, Cetuximab (Carbo, 5FU, Cetuximab)

Metastatic or Recurrent Head and Neck Squamous Cell Cancer · Metastatic or Recurrent Head and Neck Sq

#MetastaticorRecurrentHeadandNeck#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleShahid Beheshti University of M…Phase 3

injection of bevacizumab and erythropoietin (injection of bevacizumab and erythropoietin)

Refractory Diabetic Macular Edema · FRα

#FR#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleShahid Beheshti University of M…Phase 3

injection of bevacizumab (injection of bevacizumab)

Refractory Diabetic Macular Edema · FRα

#FR#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleInnoventPhase 2

Sintilimab and Bevacizumab Combined with Radiotherapy (Sintilimab and Bevacizumab Combined with Radiotherapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSecond Affiliated Hospital of G…Phase 2

TACE combined with sorafenib and tislelizumab (TACE combined with sorafenib and tislelizumab)

Hepatocellular Carcinoma Non-resectable · Hepatocellular Carcinoma Non-resectable

#HepatocellularCarcinomaNon-resec#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleM.D. Anderson Cancer CenterPhase 2

Standard Dose Bevacizumab (Standard Dose Bevacizumab)

Brain Cancer; Glioblastoma · Brain Cancer

#BrainCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleFudan UniversityPhase 2

Iparomlimab and Tuvoraleimab injection+Bevacizumab+Pemetrexed+Cisplatin (Iparomlimab and Tuvoraleimab injection+Bevacizumab+Pemetrexed+Cisplatin)

Mesothelioma · Mesothelioma

#Mesothelioma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

80 / 142 페이지

← 이전다음 →
전체 8,428개 프로그램 보기